Home Tags BI
“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”
Liew, who succeeds Jean-Michel Boers, will be responsible for developing BI’s current human pharma portfolio and preparing the organization for future launches.
The pair's “Know Your Source” initiative is the latest step in an international fight against a black market estimated at $200 billion.